The FDA’s new draft guidance on Bayesian methodology signals a shift toward more flexible, data-driven clinical trial designs, enabling sponsors to use prior data and adaptive approaches to improve ...

Business leaders want to make strong decisions and gain insights based on good data. Often, they have to look for data outside their company. This has never been truer than for generative AI models ...